Atopic Dermatitis
From the Journals
Omalizumab proves effective for severe pediatric atopic dermatitis
Treatment with omalizumab for 24 weeks reduced severity and improved quality of life in pediatric patients with severe atopic dermatitis.
From the Journals
Naturopaths emphasize role of diet in atopic dermatitis
Allopathic and naturopathic providers diverge in opinions on the role of diet in cause and treatment of AD.
Conference Coverage
Atopic dermatitis acts differently in certain populations
LAS VEGAS – AD may require different treatments depending on age, ethnicity.
From the Journals
Early onset of atopic dermatitis linked to poorer control
Children who develop atopic dermatitis in the first 2 years of life are more likely to have poorly controlled or persistent disease.
From the Journals
Skin barrier dysfunction mutations vary by race, disease persistence in children with AD
Findings may have implications for genetic test development, investigators note.
Conference Coverage
No tacrolimus/cancer link in atopic dermatitis in 10-year study
MADRID – When will the boxed warning get the boot?
Conference Coverage
Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study
MADRID – “One day after taking the first pill, you can see really nice reductions in itch at both doses, compared with placebo.”
From the Journals
Tape strips useful to identify biomarkers in skin of young children with atopic dermatitis
Adhesive tape strips can be used to collect skin samples from children with atopic dermatitis to analyze for biomarkers related to AD.
From the Journals
One-year data support dupilumab’s efficacy and safety in adolescents with AD
The monoclonal antibody dupilumab shows significant treatment response and no serious adverse events in adolescents with atopic dermatitis.
From the Journals
Apple cider vinegar soaks fall short in atopic dermatitis
Acetic acid, particularly apple cider vinegar, has become prominent among emerging natural remedies for atopic dermatitis.
From the Journals
Parent survey sheds light on suboptimal compliance with eczema medications
“Responses suggest parents may be willing to use therapies with concerning side effects if they can see a clear benefit for their child’s eczema...